Recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, this special Early Career Takeover episode explores what this annual meeting offers to researchers and clinicians at the start of their careers. Dr. Sara Fra, Dr. Cassio Murilo Hidalgo Filho, and Dr. Nan Sethakorn discuss the research presented at the meeting, the value of bringing together a multidisciplinary and international community, and the networking opportunities that helped them connect with colleagues across specialties. They reflect on their experiences in the IASLC Academy and highlight specific career development opportunities including mentorship, grants, research support, and the Early Career Forum. Guests: Sara Fra, MD Thoracic Surgeon Department of Thoracic Surgery Ramón y Cajal University Hospital Cassio Murilo Hidalgo Filho, MD Medical Oncology, Postdoctoral Fellow Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute Harvard Medical School Nan Sethakorn, MD, PhD Thoracic Oncologist Basic Translational Researcher Loyola University Chicago

The WHO Eastern Mediterranean Region (EMRO) faces unique challenges around exposures, non-conventional smoking, lung cancer screening, molecular profiling, and evolving therapies in lung cancer. To address this, the inaugural joint IASLC/EMRO workshop took place at the 2026 World Conference on Lung Cancer (WCLC) in Seoul. In this episode, Dr. Nagla Karim discusses highlights from the workshop in Arabic with Dr. Hesham Elghazaly, Dr. Arafat Tfayli, Dr. Bashir Abu Aqeel, Dr. Riad Abdel Jalil, Dr. Adda Bounedjar, and Dr. Rasha Aboelhassan. Guests: Nagla Karim, MD Professor of Medicine Director of Thoracic Oncology and Phase I Programs George Washington University Hesham Elghazaly, MD Professor of Clinical Oncology Ain Shams University Arafat Tfayli, MD Chief of Hematology/Oncology and Professor of Clinical Medicine American University of Beirut Medical Center Bashir Abu Aqeel, MD Medical Oncologist Augusta Victoria Hospital Riad Abdel Jalil, MD Thoracic Surgeon King Hussein Cancer Center Adda Bounedjar, MD Professor of Medical Oncology Blida 1 University Rasha Aboelhassan, MD Senior Oncology Consultant Nasser Institute for Research and Treatment

The 2026 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, host Dr. Chul Kim moderates a discussion in Korean about breakthrough advances in thoracic oncology presented at the conference with Dr. Ji-Youn Han, Dr. Tae Min Kim, and Dr. Sehhoon Park. Guests: Ji-Youn Han, MD, PhD Professor National Cancer Center of Korea X: @oncologyhan Tae Min Kim, MD, PhD Professor Seoul National University Hospital No Social Sehhoon Park, MD, PhD Division of Hematology-Oncology, Department of Medicine Samsung Medical Center, Sungkyunkwan University School of Medicine LinkedIn: https://www.linkedin.com/in/sehhoon-park/

In this special Patient Advocate Takeover episode, recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, patient advocates Dr. Sydney Barned and Yvonne Diaz discuss the research and conversations that caught their attention at the meeting. They reflect on access to new therapies, the importance of involving patient advocates early in clinical trial design, and how stronger communication between patients and providers can improve care. Plus, hear what they look for in new research and their perspectives on topics such as survivorship research and exercise oncology. Guests: Dr. Sydney Barned Physician and Patient Advocate Living with Stage IV ALK-positive lung cancer Yvonne Diaz Co-founder and Chair, Oncogene Cancer Research Board Member, ALK Positive Inc.

Recorded live at the IASLC World Conference on Lung Cancer (WCLC) 2026 in Seoul, this episode brings together experts from China and the U.S. to discuss the growing exchange of ideas, research, and clinical expertise between the regions. Dr. Chul Kim, Dr. Stephen Liu, Dr. Yuanyuan Zhao, and Dr. Caicun Zhou discuss key research highlights presented at WCLC and explore why lung cancer research is advancing rapidly in China, plus how stronger global collaboration can shape the future of thoracic oncology. Guests: Dr. Chul Kim Director of Thoracic Oncology Georgetown University, Washington, DC Dr. Yuanyuan Zhao Medical Oncologist & Chief Physician Sun Yat-Sen University Cancer Center Dr. Caicun Zhou Professor, Chief Physician, and Director of Medical Oncology Shanghai Pulmonary Hospital, Tongji University School of Medicine

Recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, this special Nurse Practitioner takeover episode looks at key developments in small cell lung cancer, antibody-drug conjugates, and lung cancer screening — with a focus on what APPs can take back to the clinic. Laura Macke, Stephanie McDonald, and Dr. Mary Pasquinelli discuss the studies and advances that caught their attention, including how these developments will affect patient conversations, treatment decisions, and the day-to-day work of APPs. Guests: Laura A. Macke, MS, FNP-C, AOCNP Nurse Practitioner Medstar Georgetown Cancer Institute Washington, DC Stephanie McDonald, MSN, FNP-BC, AOCNP Thoracic Oncology Nurse Practitioner Dana-Farber Cancer Institute Boston, MA Mary Pasquinelli, DNP, APRN, CTTS Lead Nurse Practitioner and Director of the Lung Screening Program University of Illinois Chicago

The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, host Dr. Marie Drösslerová moderates a discussion in Czech about breakthrough advances in thoracic oncology presented at the conference with Dr. Fernando Casas Mendez and Dr. Martin Svaton. Guests: Marie Drösslerová, MD Clinical Oncologist and Pulmonologist, Department of Pulmonology, First Faculty of Medicine Charles University/Thomayer University Hospital, Prague Fernando Casas Mendez, MD Pulmonologist, Center for Thoracic Oncology and Surgery & National Oncology Center University Hospital Motol and Homolka, Prague Martin Svaton, Ph.D. Department of Pneumology and Phtiseology University Hospital in Pilsen

The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, host Dr. Narjust Florez moderates a discussion in Spanish about breakthrough advances in thoracic oncology presented at the conference with Dr. Jorge Alatorre Alexander and Dr. Miguel Gonzalez Velez. Guests: Jorge Alatorre Alexander, MD Head of the Medical Oncology Service National Institute of Respiratory Diseases (INER) Miguel Gonzalez Velez, MD Medical Oncologist John Theurer Cancer Center at Hackensack University Medical Center

The 2026 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, host Dr. Clarissa Mathias moderates a discussion in Portuguese about breakthrough advances in thoracic oncology presented at the conference with Dr. Lilian Faroni and Dr. Vladmir Cordeiro de Lima. Guests: Lilian Faroni, MD, PhD Radiation Oncologist Oncologia D’Or Rio de Janeiro, Brazil Vladmir Cordeiro de Lima, MD, PhD Thoracic and Breast Oncologist A.C. Camargo Cancer Center, São Paulo, Brazil

In this special WCLC 2026 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu recap key findings from day three of the conference, featuring major advances that move targeted therapies earlier in the treatment of lung cancer. Guests Dr. Julia Rotow, Dr. Roy Herbst, and Dr. Daniel Tan discuss new data from DESTINY-Lung04, ADAURA, and REZILIENT3 and what these findings could mean for clinical practice. Guests: Dr. Julia Rotow Clinical Director and Research Director, Lowe Center for Thoracic Oncology Dana-Farber Cancer Institute Dr. Roy Herbst Director, Dartmouth Cancer Center Professor, Geisel School of Medicine at Dartmouth Dr. Daniel Shao-Weng Tan Senior Consultant Medical Oncologist at Division of Medical Oncology, National Cancer Centre Singapore Professor, Duke-NUS Medical School Senior Clinician-Scientist, Genome Institute of Singapore